Catheter Current Deferred Revenue vs Total Liab Analysis

VTAK Stock

0.42 0.01 2.33%

Catheter Precision financial indicator trend analysis is way more than just evaluating Catheter Precision prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Catheter Precision is a good investment. Please check the relationship between Catheter Precision Current Deferred Revenue and its Total Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Catheter Precision Current Deferred Revenue account and Total Liab. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Catheter Precision's Current Deferred Revenue and Total Liab is 0.15. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Liab in the same time period over historical financial statements of Catheter Precision, assuming nothing else is changed. The correlation between historical values of Catheter Precision's Current Deferred Revenue and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Catheter Precision are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Current Deferred Revenue i.e., Catheter Precision's Current Deferred Revenue and Total Liab go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Catheter Precision's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Catheter Precision current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.At this time, Catheter Precision's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 2.6 M this year, although Enterprise Value Multiple will most likely fall to (1.32).

	2021	2023	2024 (projected)
Interest Expense	3.1M	3.5M	3.7M
Depreciation And Amortization	1.6M	2.1M	1.3M

Interest Expense Depreciation And Amortization

Catheter Precision fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Capital Lease Obligations
Total Assets		0.47	0.44	0.56	0.98	0.68	0.4	-0.82	-0.44	0.65	0.84	0.43	0.39	0.89	0.53	0.23	-0.15	0.51	0.68	0.59	0.2	0.88	0.59	0.06	0.22	-0.18
Short Long Term Debt Total	0.47		0.44	0.73	0.42	0.87	0.31	-0.25	-0.32	0.51	0.33	0.09	0.8	0.44	-0.09	-0.16	-0.08	0.72	0.92	0.43	0.34	0.47	0.93	0.42	0.38	0.12
Other Current Liab	0.44	0.44		0.81	0.43	0.34	0.29	-0.36	-0.71	0.04	0.39	0.2	0.12	0.4	-0.3	0.2	-0.37	-0.01	0.64	0.75	0.1	0.39	0.45	0.86	0.74	-0.62
Total Current Liabilities	0.56	0.73	0.81		0.55	0.73	0.12	-0.55	-0.36	0.35	0.61	-0.12	0.56	0.68	0.06	-0.25	-0.34	0.54	0.89	0.54	0.2	0.68	0.64	0.73	0.44	-0.12
Total Stockholder Equity	0.98	0.42	0.43	0.55		0.65	0.36	-0.84	-0.4	0.66	0.85	0.39	0.32	0.89	0.54	0.2	-0.31	0.48	0.65	0.56	0.02	0.89	0.53	0.06	0.2	-0.16
Property Plant And Equipment Net	0.68	0.87	0.34	0.73	0.65		0.25	-0.51	-0.15	0.82	0.58	0.0	0.87	0.73	0.36	-0.29	-0.09	0.89	0.86	0.34	0.32	0.75	0.77	0.21	0.09	0.28
Current Deferred Revenue	0.4	0.31	0.29	0.12	0.36	0.25		0.18	-0.78	0.33	-0.14	0.85	0.26	-0.01	-0.2	0.75	0.02	-0.06	0.26	0.73	0.15	0.0	0.45	-0.03	0.49	-0.62
Net Debt	-0.82	-0.25	-0.36	-0.55	-0.84	-0.51	0.18		0.05	-0.44	-1.0	0.07	-0.17	-0.95	-0.66	0.19	0.24	-0.49	-0.54	-0.26	-0.06	-0.94	-0.29	-0.16	-0.01	-0.1
Retained Earnings	-0.44	-0.32	-0.71	-0.36	-0.4	-0.15	-0.78	0.05		-0.05	-0.07	-0.8	0.02	-0.09	0.46	-0.78	0.08	0.28	-0.39	-0.94	-0.18	-0.07	-0.47	-0.47	-0.87	0.88
Accounts Payable	0.65	0.51	0.04	0.35	0.66	0.82	0.33	-0.44	-0.05		0.47	0.12	0.66	0.63	0.58	-0.15	-0.13	0.72	0.47	0.19	0.08	0.66	0.42	-0.17	-0.18	0.31
Cash	0.84	0.33	0.39	0.61	0.85	0.58	-0.14	-1.0	-0.07	0.47		-0.06	0.24	0.97	0.63	-0.2	-0.24	0.55	0.61	0.29	0.09	0.96	0.36	0.19	0.05	0.11
Non Current Assets Total	0.43	0.09	0.2	-0.12	0.39	0.0	0.85	0.07	-0.8	0.12	-0.06		-0.08	-0.04	-0.22	0.95	0.11	-0.28	0.1	0.67	0.14	-0.05	0.36	-0.15	0.51	-0.7
Non Currrent Assets Other	0.39	0.8	0.12	0.56	0.32	0.87	0.26	-0.17	0.02	0.66	0.24	-0.08		0.43	0.29	-0.34	0.17	0.88	0.69	0.1	0.49	0.47	0.69	0.02	-0.11	0.38
Cash And Short Term Investments	0.89	0.44	0.4	0.68	0.89	0.73	-0.01	-0.95	-0.09	0.63	0.97	-0.04	0.43		0.69	-0.22	-0.23	0.68	0.69	0.32	0.13	1.0	0.44	0.15	0.0	0.14
Net Receivables	0.53	-0.09	-0.3	0.06	0.54	0.36	-0.2	-0.66	0.46	0.58	0.63	-0.22	0.29	0.69		-0.35	0.01	0.57	0.07	-0.29	0.02	0.69	-0.09	-0.52	-0.66	0.5
Common Stock Shares Outstanding	0.23	-0.16	0.2	-0.25	0.2	-0.29	0.75	0.19	-0.78	-0.15	-0.2	0.95	-0.34	-0.22	-0.35		0.09	-0.56	-0.11	0.61	0.04	-0.24	0.13	-0.1	0.53	-0.83
Non Current Liabilities Total	-0.15	-0.08	-0.37	-0.34	-0.31	-0.09	0.02	0.24	0.08	-0.13	-0.24	0.11	0.17	-0.23	0.01	0.09		0.04	-0.21	-0.14	0.85	-0.22	-0.04	-0.32	-0.12	0.11
Inventory	0.51	0.72	-0.01	0.54	0.48	0.89	-0.06	-0.49	0.28	0.72	0.55	-0.28	0.88	0.68	0.57	-0.56	0.04		0.69	-0.07	0.32	0.71	0.6	-0.06	-0.3	0.63
Other Current Assets	0.68	0.92	0.64	0.89	0.65	0.86	0.26	-0.54	-0.39	0.47	0.61	0.1	0.69	0.69	0.07	-0.11	-0.21	0.69		0.56	0.3	0.7	0.9	0.51	0.43	-0.03
Other Stockholder Equity	0.59	0.43	0.75	0.54	0.56	0.34	0.73	-0.26	-0.94	0.19	0.29	0.67	0.1	0.32	-0.29	0.61	-0.14	-0.07	0.56		0.2	0.3	0.54	0.53	0.88	-0.76
Total Liab	0.2	0.34	0.1	0.2	0.02	0.32	0.15	-0.06	-0.18	0.08	0.09	0.14	0.49	0.13	0.02	0.04	0.85	0.32	0.3	0.2		0.15	0.36	0.06	0.14	-0.01
Total Current Assets	0.88	0.47	0.39	0.68	0.89	0.75	0.0	-0.94	-0.07	0.66	0.96	-0.05	0.47	1.0	0.69	-0.24	-0.22	0.71	0.7	0.3	0.15		0.46	0.14	-0.01	0.17
Short Term Debt	0.59	0.93	0.45	0.64	0.53	0.77	0.45	-0.29	-0.47	0.42	0.36	0.36	0.69	0.44	-0.09	0.13	-0.04	0.6	0.9	0.54	0.36	0.46		0.3	0.45	-0.07
Common Stock	0.06	0.42	0.86	0.73	0.06	0.21	-0.03	-0.16	-0.47	-0.17	0.19	-0.15	0.02	0.15	-0.52	-0.1	-0.32	-0.06	0.51	0.53	0.06	0.14	0.3		0.72	-0.39
Long Term Debt	0.22	0.38	0.74	0.44	0.2	0.09	0.49	-0.01	-0.87	-0.18	0.05	0.51	-0.11	0.0	-0.66	0.53	-0.12	-0.3	0.43	0.88	0.14	-0.01	0.45	0.72		-0.75
Capital Lease Obligations	-0.18	0.12	-0.62	-0.12	-0.16	0.28	-0.62	-0.1	0.88	0.31	0.11	-0.7	0.38	0.14	0.5	-0.83	0.11	0.63	-0.03	-0.76	-0.01	0.17	-0.07	-0.39	-0.75

Click cells to compare fundamentals

Catheter Precision Account Relationship Matchups

Catheter Precision fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	44.1M	33.4M	21.0M	16.8M	30.7M	32.6M
Short Long Term Debt Total	3.5M	4.9M	2.3M	124.2K	372K	353.4K
Other Current Liab	2.6M	4.4M	4.1M	7.5M	1.7M	3.3M
Total Current Liabilities	6.8M	7.8M	5.4M	7.6M	2.5M	2.3M
Total Stockholder Equity	33.2M	21.1M	13.7M	9.3M	21.2M	21.6M
Property Plant And Equipment Net	7.9M	5.7M	3.9M	145.0K	249K	236.6K
Current Deferred Revenue	1.7M	1.7M	2.0M	1.8M	2.1M	2.0M
Net Debt	(11.1M)	(19.0M)	(12.8M)	(15.7M)	(3.2M)	(3.4M)
Retained Earnings	(117.2M)	(153.2M)	(178.3M)	(205.1M)	(275.7M)	(261.9M)
Accounts Payable	1.5M	471K	988K	92K	464K	557.1K
Cash	14.6M	23.9M	15.0M	15.9M	3.6M	3.4M
Non Current Assets Total	8.1M	5.8M	4.0M	145.0K	26.6M	27.9M
Non Currrent Assets Other	196K	123K	36K	8K	7.2K	6.8K
Cash And Short Term Investments	30.6M	23.9M	15.0M	15.9M	3.6M	3.4M
Net Receivables	786K	24K	21K	75.6K	137K	130.2K
Common Stock Shares Outstanding	10.5K	34.0K	101K	1.0M	5.5M	5.8M
Liabilities And Stockholders Equity	44.1M	33.4M	21.0M	16.8M	30.7M	32.6M
Non Current Liabilities Total	4.1M	4.5M	2.0M	247.0K	7.1M	3.9M
Inventory	2.8M	2.2M	986K	52.4K	44K	41.8K
Other Current Assets	1.9M	2.8M	1.0M	977K	415K	394.3K
Other Stockholder Equity	150.3M	174.3M	191.9M	214.4M	296.9M	163.7M
Total Liab	10.9M	12.3M	7.4M	7.6M	9.5M	8.0M
Total Current Assets	36M	27.6M	17.1M	16.8M	4.2M	4.0M
Short Term Debt	611K	1.0M	283K	36.7K	275K	361.2K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Catheter Precision is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catheter Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catheter Precision Stock. Highlighted below are key reports to facilitate an investment decision about Catheter Precision Stock:

How To Invest In Catheter

Details

Is Catheter Stock a good investment?

Details

What is Catheter Precision's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

30.61

Revenue Per Share

0.604

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.22)

Return On Equity

(0.50)

The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Catheter Current Deferred Revenue vs Total Liab Analysis

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Total Liab

Catheter Precision fundamental ratios Correlations

Catheter Precision Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Catheter Precision fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.98	Total Assets
Cash And Short Term Investments	+ 0.97	Cash
Total Current Assets	+ 0.96	Cash
Common Stock Shares Outstanding	+ 0.95	Non Current Assets Total
Short Term Debt	+ 0.93	Short Long Term Debt Total

Cash	- 1.0	Net Debt
Cash And Short Term Investments	- 0.95	Net Debt
Other Stockholder Equity	- 0.94	Retained Earnings
Total Current Assets	- 0.94	Net Debt
Long Term Debt	- 0.87	Retained Earnings
Net Debt	- 0.84	Total Stockholder Equity